Towards defining antigenic targets for antibodies in multiple sclerosis

Towards defining antigenic targets for antibodies in multiple sclerosis

Bibliographic Details
Main Authors:	Littleton, E, Dreger, M, Palace, J, Vincent, A
Format:	Conference item
Published:	2006

Similar Items

An approach to the identification of targets of autoantibodies in multiple sclerosis
by: Littleton, E, et al.
Published: (2004)

Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.
by: Littleton, E, et al.
Published: (2009)

Serum autoantibodies against intracellular antigens in multiple sclerosis
by: Lily, O, et al.
Published: (2002)

Modafinil for multiple sclerosis fatigue: does it work?
by: Littleton, E, et al.
Published: (2010)

Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients
by: Lily, O, et al.
Published: (2002)

An audit of the use of Modafinil in clinical practice for the treatment of fatigue in multiple sclerosis patients
by: Littleton, E, et al.
Published: (2005)

Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging.
by: Lee, M, et al.
Published: (1998)

The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
by: Taghipour, K, et al.
Published: (2012)

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis.
by: Sørensen, P, et al.
Published: (2005)

Making the diagnosis of multiple sclerosis.
by: Palace, J
Published: (2001)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
by: Sørensen, P, et al.
Published: (2010)

The UK Multiple Sclerosis database.
by: Palace, J, et al.
Published: (1999)

Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface
by: Domínguez-Medina, CC, et al.
Published: (2020)

New and old treatments for multiple sclerosis.
by: Palace, J
Published: (1998)

Modifying disability in progressive multiple sclerosis.
by: Palace, J, et al.
Published: (2014)

Modifying disability in progressive multiple sclerosis
by: Palace, J, et al.
Published: (2014)

New treatments and azathioprine in multiple sclerosis.
by: Palace, J, et al.
Published: (1997)

Guidelines for differential diagnosis of suspected multiple sclerosis.
by: Palace, J
Published: (2009)

Early treatment to prevent conversion of clinically isolated syndrome to clinically defined multiple sclerosis: a Cochrane metanalysis
by: Clerico, M, et al.
Published: (2008)

Multiple sclerosis: major histocompatibility complexity and antigen presentation.
by: Ramagopalan, S, et al.
Published: (2009)

Thalamic neurodegeneration in multiple sclerosis.
by: Cifelli, A, et al.
Published: (2002)

Targeting ASIC1 in primary progressive multiple sclerosis: Evidence of neuroprotection with amiloride
by: Arun, T, et al.
Published: (2013)

Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
by: Arun, T, et al.
Published: (2013)

Prevention of conversion of clinically isolated syndromes to clinically defined multiple sclerosis. Evidence from a Cochrane meta-analysis
by: Clerico, M, et al.
Published: (2008)

Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
by: Palace, J
Published: (2009)

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
by: Lily, O, et al.
Published: (2004)

Interleukin-17 expression in multiple sclerosis
by: Tzartos, J, et al.
Published: (2006)

Running a mitoxantrone service for multiple sclerosis
by: Craner, M, et al.
Published: (2006)

Toward precision phenotyping of multiple sclerosis
by: Pitt, David, et al.
Published: (2023)

Antibodies to neuronal targets in neurological and psychiatric diseases.
by: Vincent, A, et al.
Published: (2003)

A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.
by: Mcmichael, A, et al.
Published: (1979)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
by: Lampasona, V, et al.
Published: (2003)

Multiple sclerosis lesions: insights from imaging techniques.
by: Tomassini, V, et al.
Published: (2009)

Grey matter neuronal loss in multiple sclerosis
by: Cifelli, A, et al.
Published: (2002)

Recombinant interferon-beta efficacy in preventing conversion of clinically isolated syndromes to clinically defined multiple sclerosis: a Cochrane meta-analysis
by: Clerico, M, et al.
Published: (2006)

Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis
by: Cifelli, A, et al.
Published: (2003)

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.
by: Wylezinska, M, et al.
Published: (2003)

MOTOR SKILL LEARNING IN MULTIPLE SCLEROSIS
by: Tomassini, V, et al.
Published: (2009)

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.
by: Coles, A, et al.
Published: (1999)

Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis.
by: Brennan, K, et al.
Published: (2011)